XML 17 R7.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Stock Options
Number of Shares
Number of Shares
Stock Options
Unearned Shares Issued to ESOP
Retained Earnings
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Sep. 30, 2017     7,361,077        
Balance at beginning of period at Sep. 30, 2017 $ 111,000   $ 13,286   $ (397) $ 98,235 $ (124) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 12,299         12,299  
Other comprehensive income (loss) $ (10)           (10)
Exercise of stock options (in shares) 34,850   34,850        
Exercise of stock options $ 292   $ 292        
Common stock dividends (3,469)         (3,469)  
Earned ESOP shares, net of income taxes 652   $ 454   198    
Stock option compensation expense   $ 130   $ 130      
Balance at end of period (in shares) at Jun. 30, 2018     7,395,927        
Balance at end of period at Jun. 30, 2018 120,894   $ 14,162   (199) 107,065 (134) [1]
Balance at beginning of period (in shares) at Mar. 31, 2018     7,390,227        
Balance at beginning of period at Mar. 31, 2018 117,843   $ 13,891   (265) 104,349 (132) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 4,416         4,416  
Other comprehensive income (loss) (2)           (2)
Exercise of stock options (in shares)     5,700        
Exercise of stock options 58   $ 58        
Common stock dividends (1,700)         (1,700)  
Earned ESOP shares, net of income taxes 236   $ 170   66    
Stock option compensation expense   43   43      
Balance at end of period (in shares) at Jun. 30, 2018     7,395,927        
Balance at end of period at Jun. 30, 2018 120,894   $ 14,162   (199) 107,065 (134) [1]
Balance at beginning of period (in shares) at Sep. 30, 2018     7,401,177        
Balance at beginning of period at Sep. 30, 2018 124,657 [2]   $ 14,394   (133) 110,525 (129) [1]
Balance at beginning of period (in shares) at Sep. 30, 2018     7,401,177        
Balance at beginning of period at Sep. 30, 2018 124,657 [2]   $ 14,394   (133) 110,525 (129) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 17,685         17,685  
Other comprehensive income (loss) 33           33
Repurchase of common stock (in shares)     (2,831)        
Repurchase of common stock $ (70)   $ (70)        
Exercise of stock options (in shares) 37,756   37,756        
Exercise of stock options $ 340   $ 340        
Common stock dividends (5,243)         (5,243)  
Earned ESOP shares, net of income taxes $ 441   $ 308   133    
Stock option compensation expense   159   159      
Common stock issued for business combination (in shares) 904,826            
Common stock issued for business combination $ 28,267            
Balance at end of period (in shares) at Jun. 30, 2019     8,340,928        
Balance at end of period at Jun. 30, 2019 166,269   $ 43,398   0 122,904 (33) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Adoption of Accounting Standards Update (ASU) 2016-01 | Accounting Standards Update 2016-01 0         (63) 63
Balance at beginning of period (in shares) at Mar. 31, 2019     8,336,419        
Balance at beginning of period at Mar. 31, 2019 162,338   $ 43,351   0 119,032 (45) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 5,956         5,956  
Other comprehensive income (loss) 12           12
Repurchase of common stock (in shares)     (2,831)        
Repurchase of common stock (70)   $ (70)        
Exercise of stock options (in shares)     7,340        
Exercise of stock options 57   $ 57        
Common stock dividends (2,084)         (2,084)  
Earned ESOP shares, net of income taxes 7   $ 7        
Stock option compensation expense   $ 53   $ 53      
Balance at end of period (in shares) at Jun. 30, 2019     8,340,928        
Balance at end of period at Jun. 30, 2019 $ 166,269   $ 43,398   $ 0 $ 122,904 $ (33) [1]
[1] All amounts are net of income taxes.
[2] Derived from audited consolidated financial statements.